Predictive value of the systemic immune-inflammation index and geriatric nutritional risk index on the efficacy of immunotherapy and survival prognosis in advanced non-small cell lung cancer: a retrospective study

Read full text Summarise with VIRAT
Authors: Jing Wu (54032), Zhipei Duan, Jing Qian, Chengru Hu, Chao Chen, Yan Li, Tinghua Cao
Cited by: 0
References: 45

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Objective: To investigate the predictive value of the systemic immune-inflammation index (SII) and geriatric nutritional risk index (GNRI) for immunotherapy efficacy and survival prognosis in advanced non-small cell lung cancer (NSCLC).Methods: This retrospective study enrolled 152 patients with advanced NSCLC who received immunotherapy.Patients were divided into effective (n = 106) and ineffective (n = 46) groups based on treatment response.Pretreatment SII, GNRI, and programmed cell death-ligand 1 (PD-L1) levels were compared between groups.Multivariate logistc regression identified factors influencing immunotherapy efficacy.Receiver operating characteristic curve analysis evaluated the predictive value of these indicators.Kaplan-Meier method analyzed the relationship between SII, GNRI, and progression-free survival (PFS)/overall survival (OS).Cox regression analyzed their impact on survival and interaction.Results: The effective group had significantly lower pretreatment SII but higher GNRI and PD-L1 than the ineffective group (all P

Fields of Study & Subjects

Inflammatory Biomarkers in Disease Prognosis Lung Cancer Research Studies Cancer Immunotherapy and Biomarkers

Publication details

Journal / source
American Journal of Cancer Research
Volume
16
Issue
3
Pages
920–936
Publication date
1 January 2026
Language
EN